A PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY AND EFFICACY OF SUBCUTANEOUS GOLIMUMAB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PURSUIT-MAINTENANCE

(1) U Hospital, Gasthuisberg

(2) U Western Ontario

(3) Janssen R&D

(4) CHU

(5) U für Innere Medizin IV

(6) Alfred Hospital

(7) Oregon Hlth Sciences U

(8) Orebro U Hospital

(9) UCSD



This item was part of the Anti-TNF therapy in IBD session at 20th United European Gastroenterology Week

This item can be cited as: Gut 2012; 61 (Suppl 3) A78